MoS Mandaviya visits SII Pune plant, assures Govt aid in ramping up Covishield production

Published On 2021-07-04 04:30 GMT   |   Update On 2021-07-04 04:30 GMT

New Delhi: Minister of State for Chemicals and Fertilisers Mansukh Mandaviya on Friday visited the Pune-based vaccine manufacturing plant of Serum Institute of India (SII).The minister also went to know about the production process as well as reviewed the roll out of the COVID-19 vaccine ''Covishield'' from the facility."Visited @SerumInstIndia in Pune today. Got further acquainted with...

Login or Register to read the full article

New Delhi: Minister of State for Chemicals and Fertilisers Mansukh Mandaviya on Friday visited the Pune-based vaccine manufacturing plant of Serum Institute of India (SII).

The minister also went to know about the production process as well as reviewed the roll out of the COVID-19 vaccine ''Covishield'' from the facility.

"Visited @SerumInstIndia in Pune today. Got further acquainted with the vaccination production at their plant. Deeply appreciating their exemplary role during the pandemic, I assured them of all Government support in ramping up vaccine production for ensuring #FreeVaccineForAll," Mandaviya tweeted.

Department of Pharmaceuticals Secretary S Aparna also visited the plant along with the minister.

Read also: Submit results on adult trials first: Govt panel to Serum Institute on Covavax trials for children

SII is the world''s largest vaccine manufacturer by number of doses produced and sold globally.

Later in the day, Mandaviya also inaugurated the facility to produce alcoholic hand disinfectant at Hindustan Antibiotics Ltd''s plant at Pimpri, Pune.

Read also: Covishield to get EMA approval in a month: Serum Institute CEO Adar Poonawalla



Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News